<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05091398</url>
  </required_header>
  <id_info>
    <org_study_id>34779/7/21</org_study_id>
    <nct_id>NCT05091398</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane, Paravertebral Versus Intercostal Nerve Block for VATS Surgery</brief_title>
  <official_title>Erector Spinae Plane, Paravertebral Versus Intercostal Nerve Block for VATS Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal analgesia method in video-assisted thoracoscopic surgery (VATS) remains&#xD;
      controversial. 105 patients scheduled to undergo video-assisted thoracic surgery under&#xD;
      general anesthesia will be included. Patients will be randomly allocated to receive&#xD;
      ultrasound-guided ESP blocks on T4 and T6 levels (Group ESPB, n = 35),PVB (Group PVB, n = 35)&#xD;
      after the anesthesia induction and turning the patient in the lateral position or (Group&#xD;
      ICNB, n=35) with 30 mL 0.5% bupivacaine +50 µ adrenaline will be injected by the surgeon&#xD;
      through the thoracoscope .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard general anesthesia was applied Patients will be randomly allocated to receive single&#xD;
      shot of ESP blocks (Group ESPB), Paravertebral blocks (Group PVB) or (Group ICNB )at T4 and&#xD;
      T6 levels according to a random number list that will be generated by a computer and will be&#xD;
      stored in sealed envelopes. An independent experienced anesthesiologist will perform the&#xD;
      first two blocks or surgeon will perform the third one through the thoracoscope according to&#xD;
      the random number. The study coordinator, attending anesthesiologist, data collection&#xD;
      resident and the patients will be all blinded to the treatment group assignment. All blocks&#xD;
      will be applied on patient's back in a lateral position. Postoperative analgesia regimen&#xD;
      consisted of a continuous infusion of iv iboprofen and morphine as a second rescue drug.&#xD;
      Demographic data, past medical history, surgical and anesthetic data will be documented.&#xD;
      Postoperative pain scores, consumption of analgesia and quality of recovery will be recorded&#xD;
      to evaluate the analgesic effect.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 5, 2021</start_date>
  <completion_date type="Actual">November 5, 2021</completion_date>
  <primary_completion_date type="Actual">November 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>end tidal sevoflurane</measure>
    <time_frame>150 minutes</time_frame>
    <description>intraoperative end tidal sevoflurane</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>150 minutes</time_frame>
    <description>Intraoperative blood pressure in mmHg</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Thoracic</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound-guided erector spinae block on T4 and T6 levels after the anesthesia induction and turning the patient in the lateral position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound-guided paravertebral block on T4 and T6 levels after the anesthesia induction and turning the patient in the lateral position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound-guided intercostal nerve block on T4 and T6 levels after the anesthesia induction and turning the patient in the lateral position</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regional analgesia of thoracic surgical patients</intervention_name>
    <description>ultrasound-guided erector spinae block on T4 and T6 levels ,paravertebral block or intercostal nerve block after the anesthesia induction and turning the patient in the lateral position with 30 mL 0.5% bupivacaine +50 µ adrenaline will be injected by the surgeon through the thoracoscope .</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_label>Group III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I and II patients&#xD;
&#xD;
          -  Thoracic surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulation defect&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mona Mohamed Mogahed</name>
      <address>
        <city>Tanta</city>
        <state>Elgharbia</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 1, 2021</study_first_submitted>
  <study_first_submitted_qc>October 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Mona Mohamed Mogahed</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Erector spinae plane</keyword>
  <keyword>paravertebral</keyword>
  <keyword>intercostal nerve block</keyword>
  <keyword>VATS</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

